These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

981 related articles for article (PubMed ID: 16574264)

  • 1. A low molecular weight fraction of polyethylenimine (PEI) displays increased transfection efficiency of DNA and siRNA in fresh or lyophilized complexes.
    Werth S; Urban-Klein B; Dai L; Höbel S; Grzelinski M; Bakowsky U; Czubayko F; Aigner A
    J Control Release; 2006 May; 112(2):257-70. PubMed ID: 16574264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyethylenimine PEI F25-LMW allows the long-term storage of frozen complexes as fully active reagents in siRNA-mediated gene targeting and DNA delivery.
    Höbel S; Prinz R; Malek A; Urban-Klein B; Sitterberg J; Bakowsky U; Czubayko F; Aigner A
    Eur J Pharm Biopharm; 2008 Sep; 70(1):29-41. PubMed ID: 18499413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab.
    Höbel S; Koburger I; John M; Czubayko F; Hadwiger P; Vornlocher HP; Aigner A
    J Gene Med; 2010 Mar; 12(3):287-300. PubMed ID: 20052738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo.
    Urban-Klein B; Werth S; Abuharbeid S; Czubayko F; Aigner A
    Gene Ther; 2005 Mar; 12(5):461-6. PubMed ID: 15616603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.
    Günther M; Lipka J; Malek A; Gutsch D; Kreyling W; Aigner A
    Eur J Pharm Biopharm; 2011 Apr; 77(3):438-49. PubMed ID: 21093588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo pharmacokinetics, tissue distribution and underlying mechanisms of various PEI(-PEG)/siRNA complexes.
    Malek A; Merkel O; Fink L; Czubayko F; Kissel T; Aigner A
    Toxicol Appl Pharmacol; 2009 Apr; 236(1):97-108. PubMed ID: 19371615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposome-polyethylenimine complexes for enhanced DNA and siRNA delivery.
    Schäfer J; Höbel S; Bakowsky U; Aigner A
    Biomaterials; 2010 Sep; 31(26):6892-900. PubMed ID: 20561681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyethylenimine (PEI)/siRNA-mediated gene knockdown in vitro and in vivo.
    Höbel S; Aigner A
    Methods Mol Biol; 2010; 623():283-97. PubMed ID: 20217558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.
    Aigner A
    J Biotechnol; 2006 Jun; 124(1):12-25. PubMed ID: 16413079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PEG conjugated VEGF siRNA for anti-angiogenic gene therapy.
    Kim SH; Jeong JH; Lee SH; Kim SW; Park TG
    J Control Release; 2006 Nov; 116(2):123-9. PubMed ID: 16831481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Target specific tumor treatment by VEGF siRNA complexed with reducible polyethyleneimine-hyaluronic acid conjugate.
    Park K; Lee MY; Kim KS; Hahn SK
    Biomaterials; 2010 Jul; 31(19):5258-65. PubMed ID: 20378167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The induction of tumor apoptosis in B16 melanoma following STAT3 siRNA delivery with a lipid-substituted polyethylenimine.
    Alshamsan A; Hamdy S; Samuel J; El-Kadi AO; Lavasanifar A; Uludağ H
    Biomaterials; 2010 Feb; 31(6):1420-8. PubMed ID: 19913908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective polyethylenimine-mediated gene transfer into human endothelial cells.
    Zaric V; Weltin D; Erbacher P; Remy JS; Behr JP; Stephan D
    J Gene Med; 2004 Feb; 6(2):176-84. PubMed ID: 14978771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of homobifunctional crosslinkers on nucleic acids delivery ability of PEI nanoparticles.
    Swami A; Goyal R; Tripathi SK; Singh N; Katiyar N; Mishra AK; Gupta KC
    Int J Pharm; 2009 Jun; 374(1-2):125-38. PubMed ID: 19446769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A unique and highly efficient non-viral DNA/siRNA delivery system based on PEI-bisepoxide nanoparticles.
    Swami A; Kurupati RK; Pathak A; Singh Y; Kumar P; Gupta KC
    Biochem Biophys Res Commun; 2007 Nov; 362(4):835-41. PubMed ID: 17822674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degradable polyethylenimines as DNA and small interfering RNA carriers.
    Jere D; Jiang HL; Arote R; Kim YK; Choi YJ; Cho MH; Akaike T; Cho CS
    Expert Opin Drug Deliv; 2009 Aug; 6(8):827-34. PubMed ID: 19558333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate cancer cell-specific VEGF siRNA delivery system using cell targeting peptide conjugated polyplexes.
    Kim SH; Lee SH; Tian H; Chen X; Park TG
    J Drug Target; 2009 May; 17(4):311-7. PubMed ID: 19242850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel shielded transferrin-polyethylene glycol-polyethylenimine/DNA complexes for systemic tumor-targeted gene transfer.
    Kursa M; Walker GF; Roessler V; Ogris M; Roedl W; Kircheis R; Wagner E
    Bioconjug Chem; 2003; 14(1):222-31. PubMed ID: 12526712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-Succinyl-chitosan grafted with low molecular weight polyethylenimine as a serum-resistant gene vector.
    Lu B; Sun YX; Li YQ; Zhang XZ; Zhuo RX
    Mol Biosyst; 2009 Jun; 5(6):629-37. PubMed ID: 19462020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled cytoplasmic and nuclear localization of plasmid DNA and siRNA by differentially tailored polyethylenimine.
    Shim MS; Kwon YJ
    J Control Release; 2009 Feb; 133(3):206-13. PubMed ID: 18992289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.